Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexios Matikas

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Critical Reviews in Oncology/Hematology|October 22, 2023
The ever-expanding landscape of antibody-drug conjugates (ADCs) in solid tumors: A systematic reviewPanagiotis Filis, Ioannis Zerdes, Theodora Soumala, et al.
Translational Lung Cancer Research|September 22, 2016
Targeting angiogenesis in small cell lung cancerMichalis Stratigos, Alexios Matikas, Alexandra Voutsina, et al.
Case Reports in Oncological Medicine|June 20, 2015
Prolonged Complete Response in a Patient with Metastatic Pancreatic Adenocarcinoma after FOLFIRINOX Chemotherapy and Maintenance with FOLFIRIChristos Nikolaou, Alexios Matikas, Maria Papavasilopoulou, et al.
Cancers|May 8, 2019
Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer ImmunotherapySebastian Chrétien, Ioannis Zerdes, Jonas Bergh, et al.
Breast Care (Basel, Switzerland)|October 4, 2021
Expert Discussion: HER2-Positive Breast CancerTheodoros Foukakis, Alexios Matikas, Olga Oikonomidou, et al.
Oncogene|May 17, 2018
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlationsIoannis Zerdes, Alexios Matikas, Jonas Bergh, et al.
Breast Cancer Research and Treatment|April 24, 2022
Women with short survival after diagnosis of metastatic breast cancer: a population-based registry studyCaroline Boman, Luisa Edman Kessler, Jonas Bergh, et al.
Breast Cancer Research : BCR|December 24, 2025
Computational decoding of cell-cycle phase effects on cancer hallmarks across breast cancer subtypesMiguel Castresana-Aguirre, Alexios Matikas, Linda S Lindström, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2025
Long-term outcome for neoadjuvant versus adjuvant chemotherapy in early breast cancer and the prognostic impact of nodal therapy response: A population-based studyXingrong Liu, Louise Eriksson Bergman, Caroline Boman, et al.
Breast (Edinburgh, Scotland)|June 13, 2026
A nationwide population-based study on the incidence and prognosis of HER2-positive breast cancer eligible for adjuvant pertuzumab in the modern era of neoadjuvant therapyAntonis Valachis, Xingrong Liu, Balazs Acs, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Critical Reviews in Oncology/Hematology|October 22, 2023
The ever-expanding landscape of antibody-drug conjugates (ADCs) in solid tumors: A systematic reviewPanagiotis Filis, Ioannis Zerdes, Theodora Soumala, et al.
Translational Lung Cancer Research|September 22, 2016
Targeting angiogenesis in small cell lung cancerMichalis Stratigos, Alexios Matikas, Alexandra Voutsina, et al.
Case Reports in Oncological Medicine|June 20, 2015
Prolonged Complete Response in a Patient with Metastatic Pancreatic Adenocarcinoma after FOLFIRINOX Chemotherapy and Maintenance with FOLFIRIChristos Nikolaou, Alexios Matikas, Maria Papavasilopoulou, et al.
Cancers|May 8, 2019
Beyond PD-1/PD-L1 Inhibition: What the Future Holds for Breast Cancer ImmunotherapySebastian Chrétien, Ioannis Zerdes, Jonas Bergh, et al.
Breast Care (Basel, Switzerland)|October 4, 2021
Expert Discussion: HER2-Positive Breast CancerTheodoros Foukakis, Alexios Matikas, Olga Oikonomidou, et al.
Oncogene|May 17, 2018
Genetic, transcriptional and post-translational regulation of the programmed death protein ligand 1 in cancer: biology and clinical correlationsIoannis Zerdes, Alexios Matikas, Jonas Bergh, et al.
Breast Cancer Research and Treatment|April 24, 2022
Women with short survival after diagnosis of metastatic breast cancer: a population-based registry studyCaroline Boman, Luisa Edman Kessler, Jonas Bergh, et al.
Breast Cancer Research : BCR|December 24, 2025
Computational decoding of cell-cycle phase effects on cancer hallmarks across breast cancer subtypesMiguel Castresana-Aguirre, Alexios Matikas, Linda S Lindström, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 10, 2025
Long-term outcome for neoadjuvant versus adjuvant chemotherapy in early breast cancer and the prognostic impact of nodal therapy response: A population-based studyXingrong Liu, Louise Eriksson Bergman, Caroline Boman, et al.
Breast (Edinburgh, Scotland)|June 13, 2026
A nationwide population-based study on the incidence and prognosis of HER2-positive breast cancer eligible for adjuvant pertuzumab in the modern era of neoadjuvant therapyAntonis Valachis, Xingrong Liu, Balazs Acs, et al.
Pageof 10